MMP9 and breast carcinoma: Neutrophil gelatinase-associated lipocalin–matrix metalloproteinase-9 (MMP-9) complexes were identified in nearly 84% of urine sample from breast cancer patients while being absent from matched control samples (Fernandez et al, 2005).